EAM Investors’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

EAM Investors’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-25,164	Closed	-$1.34M	–	428
2016 Q1	$1.34M	Sell	25,164 -2,089	-8%	-$154K	0.21%	198
2015 Q4	$3.08M	Buy	+27,253	New	+$3M	0.4%	105
2015 Q2	–	Sell	-17,070	Closed	-$987K	–	444
2015 Q1	$987K	Sell	17,070 -13,488	-44%	-$573K	0.11%	304
2014 Q4	$985K	Sell	30,558 -19,307	-39%	-$580K	0.14%	291
2014 Q3	$1.22M	Hold	49,865	–	–	0.25%	198
2014 Q2	$884K	Sell	49,865 -97,580	-66%	-$1.57M	0.17%	301
2014 Q1	$2.95M	Sell	147,445 -36,876	-20%	-$715K	0.53%	32
2013 Q4	$3.09M	Sell	184,321 -22,612	-11%	-$313K	0.55%	32
2013 Q3	$2.2M	Buy	+206,933	New	+$1.81M	0.44%	58

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

EAM Investors's ANAC Position: Q2 2016 in Review

EAM Investors sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 25,164 shares — an estimated $1.34M sold.

EAM Investors first reported a position in ANAC in Q3 2013 and held it in 9 quarters. The position peaked at $3.09M in Q4 2013. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

EAM Investors reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
EAM Investors sold 25,164 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $1.34M.
EAM Investors first reported a position in ANACOR PHARMACEUTICALS INC COM in Q3 2013 and held it in 9 quarters.
EAM Investors's ANACOR PHARMACEUTICALS INC COM position peaked at $3.09M in Q4 2013.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on EAM Investors's 13F filing for Q2 2016, filed 4 Aug 2016.